Skip to main content

Table 1 Summary of expression and function of SLIT1, SLIT2, SLIT3, ROBO1, ROBO2 and ROBO4 in cancers

From: The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers

Gene

Expression in cancers

Function

Metastasis

References

SLIT1

Upregulation

Prostate cancer

Increased expression in prostate tumors

 

[97]

SLIT2

Downregulation

Colorectal cancer

Tumour suppress

Suppress

[10, 79, 80]

Esophageal squamous cell carcinoma

Correlated with poor overall survival

Suppress

[84]

Intestinal tumors

Promotes intestinal tumorigenesis

 

[88]

Breast cancer

Tumour suppressor and low expression is associated with poor survival and increased metastasis

Suppress

[89, 90, 98] [51]

Lung cancer

Tumour suppressor

Suppress

[10, 92, 101] [102]

Advanced gastric cancer

Knockdown of SLIT2 in gastric cancer cells promotes cell growth and metastasis in vitro and in vivo

Suppress

[66, 67]

Upregulation

Colorectal cancer

Induce malignant transformation of colorectal epithelial cell and tumor metastasis

Promote

[78] [62]

SLIT3

Downregulation

Colorectal cancer

SLIT3 is frequently methylated in colorectal cancers

 

[10, 77]

Breast cancer

SLIT3 methylation in breast tumours correlated with reduced SLIT3 expression

 

[10]

Liver cancer

SLIT3 was significantly down-regulated in cell lines with high-AFP background

 

[75]

ROBO1

Downregulation

Breast cancer

A high frequency of allele loss

 

[18] [69]

Lung cancer

A high frequency of allele loss

 

[69]

Prostate cancer

ROBO1 expression was significantly reduced in prostate tumors

 

[97]

Upregulation

Gastric cancer

SLIT2 interacted with ROBO1 to promote gastric cancer invasion

Promote

[62, 64] [63]

Liver cancer

Overexpressed in and shed into serum for prediction of tumor stage and differentiation status

 

[76] [75]

Intestinal tumors

Promotes intestinal tumorigenesis

Promote

[88]

Pancreatic cancer

Contribute to the lymphatic metastasis of pancreatic cancer

Promote

[86]

Colorectal cancer

ROBO1 was significantly associated with an increased metastatic risk and poorer overall survival in colorectal carcinoma patients

Promote

[77]

ROBO2

Upregulation

Liver cancer

ROBO2 were significantly up-regulated cell lines with high-AFP background

 

[75]

ROBO4

Downregulation

Liver cancer

ROBO4 could discriminate poorly differentiated HCC from other subgroups

 

[75]